Joshua C. Hurwitz
Papers
1
Total Citations
3
H-Index
1
About
Joshua C. Hurwitz is a radiation oncologist whose research focuses on the application of stereotactic body radiation therapy (SBRT) for the curative treatment of prostate cancer, particularly in challenging clinical scenarios. His major contribution lies in demonstrating the feasibility and safety of SBRT for patients with ultralarge prostate glands (≥100 cc), a population historically excluded from such protocols due to technical and toxicity concerns. His landmark 2023 paper on this topic, which has garnered early citations, provides critical evidence that SBRT can be effectively delivered in these cases, expanding treatment options for patients with significant prostate enlargement. This work addresses a key gap in the literature, as standard SBRT trials often limited enrollment based on gland size. Hurwitz’s research has immediate clinical relevance, offering a non-invasive, high-precision alternative to surgery or longer radiation courses. His findings contribute to the growing body of evidence supporting SBRT’s role in prostate cancer management, with potential to reduce treatment burden while maintaining curative intent.
Research Focus
Key Achievements
Top Papers
- 1